{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:26:15Z","timestamp":1760865975283,"version":"3.27.0"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:p>Management of obesity and decompensated cirrhosis in those requiring liver transplantation (LT) is a challenging dilemma. Because of concerns for perioperative complications, many centers avoid transplant in those with a body mass index (BMI) greater than 40 kg\/m<jats:sup>2<\/jats:sup>. Bariatric surgery is associated with increased risk attributable to complications of portal hypertension, including variceal rupture. Therefore, weight loss and LT options are limited. Several new classes of weight loss drugs are commercially available, including the anoretic, lorcaserin. This case illustrates the successful use of lorcaserin in a morbidly obese individual with decompensated cirrhosis evaluated for LT listing. (H<jats:sc>epatology<\/jats:sc> 2016;64:301\u2013302)<\/jats:p>","DOI":"10.1002\/hep.28556","type":"journal-article","created":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T06:59:43Z","timestamp":1458370783000},"page":"301-302","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Lorcaserin Use in the Management of Morbid Obesity in a Pre\u2010Liver Transplant Patient"],"prefix":"10.1097","volume":"64","author":[{"given":"Julio A.","family":"Gutierrez","sequence":"first","affiliation":[{"name":"Department of Hepatology, Texas Liver Institute,University of Texas Health Science Center,San Antonio,TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Landaverde","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Texas Liver Institute,University of Texas Health Science Center,San Antonio,TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer T.","family":"Wells","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Texas Liver Institute,University of Texas Health Science Center,San Antonio,TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Poordad","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Texas Liver Institute,University of Texas Health Science Center,San Antonio,TX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2016,4,15]]},"reference":[{"key":"hep28556-bib-0001-20241017","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","year":"2015","journal-title":"Gastroenterology"},{"key":"hep28556-bib-0002-20241017","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00535-015-1114-8","article-title":"Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery","volume":"51","year":"2016","journal-title":"J Gastroenterol"},{"key":"hep28556-bib-0003-20241017","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/jhep.2002.30318","article-title":"Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States","volume":"35","year":"2002","journal-title":"Hepatology"},{"key":"hep28556-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1517\/14656566.2015.1096345","article-title":"Lorcaserin Hcl for the treatment of obesity","volume":"16","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"hep28556-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1210\/jc.2011-1256","article-title":"A one\u2010year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM Trial","volume":"96","year":"2011","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.28556","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201607000-00036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T23:36:00Z","timestamp":1729208160000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201607000-00036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,15]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.28556","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"type":"print","value":"0270-9139"},{"type":"electronic","value":"1527-3350"}],"subject":[],"published":{"date-parts":[[2016,4,15]]},"assertion":[{"value":"2015-12-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-03-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}